Reviva Historical Balance Sheet

RVPHW Stock

USD 0.13 0.02 13.33%

Trend analysis of Reviva Pharmaceuticals Holdings balance sheet accounts such as Total Stockholder Equity of 10.4 M, Property Plant And Equipment Net of 2.2 K, Current Deferred Revenue of 2.2 M or Accounts Payable of 2 M provides information on Reviva Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Reviva Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Reviva Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Reviva Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Reviva Pharmaceuticals is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

About Reviva Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Reviva Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Reviva Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Reviva Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Reviva currently owns. An asset can also be divided into two categories, current and non-current.

Reviva Pharmaceuticals Balance Sheet Chart

At this time, Reviva Pharmaceuticals' Other Current Liabilities is fairly stable compared to the past year. Total Current Liabilities is likely to climb to about 18 M in 2024, whereas Net Debt is likely to drop (17.5 M) in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Cash Short Term Debt

Total Assets

Total assets refers to the total amount of Reviva Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Reviva Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Reviva Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Reviva Pharmaceuticals Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash

Cash refers to the most liquid asset of Reviva Pharmaceuticals, which is listed under current asset account on Reviva Pharmaceuticals Holdings balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Reviva Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Reviva Pharmaceuticals account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Most accounts from Reviva Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Reviva Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Reviva Pharmaceuticals Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

	2023	2024 (projected)
Short and Long Term Debt Total	3.4M	3.0M
Total Assets	23.7M	18.2M

Short Long Term Debt Total Total Assets

Reviva Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		-0.47	0.88	0.26	0.95	0.9	-0.47	-0.99	-0.72	0.7	1.0	-0.96	-0.47	1.0	0.91	0.87	-0.47	-0.98	0.84	0.3	0.96	0.91	-0.47	1.0	-0.91	0.95
Short Long Term Debt Total	-0.47		-0.74	-0.88	-0.32	-0.37	1.0	0.46	0.86	-0.54	-0.48	0.61	1.0	-0.43	-0.46	-0.57	1.0	0.49	-0.54	-0.89	-0.39	-0.61	1.0	-0.47	0.52	-0.33
Other Current Liab	0.88	-0.74		0.61	0.75	0.8	-0.74	-0.87	-0.93	0.87	0.89	-0.97	-0.74	0.87	0.84	0.94	-0.74	-0.93	0.92	0.65	0.81	0.89	-0.74	0.88	-0.86	0.76
Total Current Liabilities	0.26	-0.88	0.61		0.0	0.15	-0.88	-0.19	-0.82	0.55	0.27	-0.42	-0.88	0.21	0.28	0.56	-0.88	-0.3	0.57	1.0	0.09	0.33	-0.88	0.26	-0.24	0.01
Total Stockholder Equity	0.95	-0.32	0.75	0.0		0.86	-0.32	-0.98	-0.51	0.51	0.94	-0.88	-0.32	0.96	0.83	0.69	-0.32	-0.91	0.64	0.05	0.97	0.87	-0.32	0.95	-0.89	1.0
Property Plant And Equipment Net	0.9	-0.37	0.8	0.15	0.86		-0.37	-0.91	-0.68	0.79	0.91	-0.88	-0.37	0.91	0.99	0.83	-0.37	-0.91	0.75	0.19	0.95	0.95	-0.37	0.9	-0.97	0.86
Current Deferred Revenue	-0.47	1.0	-0.74	-0.88	-0.32	-0.37		0.46	0.86	-0.54	-0.48	0.61	1.0	-0.43	-0.46	-0.57	1.0	0.49	-0.54	-0.89	-0.39	-0.61	1.0	-0.47	0.52	-0.33
Net Debt	-0.99	0.46	-0.87	-0.19	-0.98	-0.91	0.46		0.68	-0.67	-0.99	0.96	0.46	-0.99	-0.9	-0.82	0.46	0.98	-0.78	-0.23	-0.98	-0.93	0.46	-0.99	0.94	-0.98
Retained Earnings	-0.72	0.86	-0.93	-0.82	-0.51	-0.68	0.86	0.68		-0.87	-0.73	0.84	0.86	-0.69	-0.76	-0.89	0.86	0.77	-0.86	-0.85	-0.62	-0.8	0.86	-0.72	0.74	-0.52
Accounts Payable	0.7	-0.54	0.87	0.55	0.51	0.79	-0.54	-0.67	-0.87		0.71	-0.82	-0.54	0.69	0.83	0.92	-0.54	-0.8	0.88	0.58	0.67	0.79	-0.54	0.7	-0.77	0.53
Cash	1.0	-0.48	0.89	0.27	0.94	0.91	-0.48	-0.99	-0.73	0.71		-0.97	-0.48	1.0	0.92	0.88	-0.48	-0.98	0.85	0.31	0.96	0.92	-0.48	1.0	-0.92	0.95
Non Current Assets Total	-0.96	0.61	-0.97	-0.42	-0.88	-0.88	0.61	0.96	0.84	-0.82	-0.97		0.61	-0.96	-0.9	-0.93	0.61	0.99	-0.9	-0.47	-0.91	-0.93	0.61	-0.96	0.92	-0.89
Non Currrent Assets Other	-0.47	1.0	-0.74	-0.88	-0.32	-0.37	1.0	0.46	0.86	-0.54	-0.48	0.61		-0.43	-0.46	-0.57	1.0	0.49	-0.54	-0.89	-0.39	-0.61	1.0	-0.47	0.52	-0.33
Cash And Short Term Investments	1.0	-0.43	0.87	0.21	0.96	0.91	-0.43	-0.99	-0.69	0.69	1.0	-0.96	-0.43		0.91	0.86	-0.43	-0.98	0.83	0.26	0.96	0.9	-0.43	1.0	-0.91	0.96
Common Stock Total Equity	0.91	-0.46	0.84	0.28	0.83	0.99	-0.46	-0.9	-0.76	0.83	0.92	-0.9	-0.46	0.91		0.87	-0.46	-0.91	0.8	0.32	0.93	0.96	-0.46	0.91	-0.97	0.83
Common Stock Shares Outstanding	0.87	-0.57	0.94	0.56	0.69	0.83	-0.57	-0.82	-0.89	0.92	0.88	-0.93	-0.57	0.86	0.87		-0.57	-0.92	0.99	0.6	0.77	0.83	-0.57	0.87	-0.8	0.7
Short Term Investments	-0.47	1.0	-0.74	-0.88	-0.32	-0.37	1.0	0.46	0.86	-0.54	-0.48	0.61	1.0	-0.43	-0.46	-0.57		0.49	-0.54	-0.89	-0.39	-0.61	1.0	-0.47	0.52	-0.33
Non Current Liabilities Total	-0.98	0.49	-0.93	-0.3	-0.91	-0.91	0.49	0.98	0.77	-0.8	-0.98	0.99	0.49	-0.98	-0.91	-0.92	0.49		-0.89	-0.35	-0.94	-0.92	0.49	-0.98	0.92	-0.92
Other Stockholder Equity	0.84	-0.54	0.92	0.57	0.64	0.75	-0.54	-0.78	-0.86	0.88	0.85	-0.9	-0.54	0.83	0.8	0.99	-0.54	-0.89		0.61	0.7	0.75	-0.54	0.84	-0.72	0.65
Total Liab	0.3	-0.89	0.65	1.0	0.05	0.19	-0.89	-0.23	-0.85	0.58	0.31	-0.47	-0.89	0.26	0.32	0.6	-0.89	-0.35	0.61		0.14	0.37	-0.89	0.3	-0.28	0.06
Net Invested Capital	0.96	-0.39	0.81	0.09	0.97	0.95	-0.39	-0.98	-0.62	0.67	0.96	-0.91	-0.39	0.96	0.93	0.77	-0.39	-0.94	0.7	0.14		0.95	-0.39	0.96	-0.97	0.97
Property Plant And Equipment Gross	0.91	-0.61	0.89	0.33	0.87	0.95	-0.61	-0.93	-0.8	0.79	0.92	-0.93	-0.61	0.9	0.96	0.83	-0.61	-0.92	0.75	0.37	0.95		-0.61	0.91	-0.99	0.87
Short Long Term Debt	-0.47	1.0	-0.74	-0.88	-0.32	-0.37	1.0	0.46	0.86	-0.54	-0.48	0.61	1.0	-0.43	-0.46	-0.57	1.0	0.49	-0.54	-0.89	-0.39	-0.61		-0.47	0.52	-0.33
Total Current Assets	1.0	-0.47	0.88	0.26	0.95	0.9	-0.47	-0.99	-0.72	0.7	1.0	-0.96	-0.47	1.0	0.91	0.87	-0.47	-0.98	0.84	0.3	0.96	0.91	-0.47		-0.91	0.95
Capital Stock	-0.91	0.52	-0.86	-0.24	-0.89	-0.97	0.52	0.94	0.74	-0.77	-0.92	0.92	0.52	-0.91	-0.97	-0.8	0.52	0.92	-0.72	-0.28	-0.97	-0.99	0.52	-0.91		-0.9
Net Working Capital	0.95	-0.33	0.76	0.01	1.0	0.86	-0.33	-0.98	-0.52	0.53	0.95	-0.89	-0.33	0.96	0.83	0.7	-0.33	-0.92	0.65	0.06	0.97	0.87	-0.33	0.95	-0.9

Click cells to compare fundamentals

Reviva Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
V	Visa Class A
MSFT	Microsoft

Additional Tools for Reviva Stock Analysis

When running Reviva Pharmaceuticals' price analysis, check to measure Reviva Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reviva Pharmaceuticals is operating at the current time. Most of Reviva Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reviva Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reviva Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reviva Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Reviva Historical Balance Sheet

About Reviva Balance Sheet Analysis

Reviva Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash

Reviva Pharmaceuticals balance sheet Correlations

Reviva Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Reviva Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Current Deferred Revenue	+ 1.0	Short Long Term Debt Total
Non Currrent Assets Other	+ 1.0	Short Long Term Debt Total
Short Term Investments	+ 1.0	Short Long Term Debt Total

Capital Stock	- 0.99	Property Plant And Equipment Gross
Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Cash	- 0.99	Net Debt
Net Debt	- 0.99	Total Assets
Total Current Assets	- 0.98	Non Current Liabilities Total